Science Explorer Interactive view Map
Company · Rotterdam · Netherlands

Centrient Pharmaceuticals (Netherlands)

Research works
5
▼ 32% vs 2013–17
Citations
55
12.0 per fractional work
Top-10% rate
0.0%
record average 16.5%
Open access
46%
world 28%

Not ranked overall: Centrient Pharmaceuticals (Netherlands) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Which research topics does Centrient Pharmaceuticals (Netherlands) publish most on?

By volume in 2022–2025: Laser Applications in Dentistry and Medicine, Diabetic Foot Ulcer Assessment and Management and Wound Healing and Treatments.

  1. 1 Laser Applications in Dentistry and Medicine Radiology, Nuclear Medicine and Imaging 0 works
  2. 2 Diabetic Foot Ulcer Assessment and Management Endocrinology, Diabetes and Metabolism 0 works
  3. 3 Wound Healing and Treatments Rehabilitation 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available45.5%not open54.5%

World: 28% of research is openly available.

with international co-authors45.5%domestic only54.5%

World: 19% is written across borders.

How has Centrient Pharmaceuticals (Netherlands)'s research output changed?

Output in 2018–2022 was 32% lower than in 2013–2017.

2005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Rotterdam

All research institutions in Rotterdam

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.